Please use this identifier to cite or link to this item: https://hdl.handle.net/10316/111170
DC FieldValueLanguage
dc.contributor.authorHofmanova, Tereza-
dc.contributor.authorMarques, Carolina-
dc.contributor.authorGarcía-Sosa, Alfonso T.-
dc.contributor.authorLópez, Óscar-
dc.contributor.authorLeitzbach, Luisa-
dc.contributor.authorCarreiro, Elisabete P.-
dc.contributor.authorGonzález-Bakker, Aday-
dc.contributor.authorPuerta, Adrián-
dc.contributor.authorStark, Holger-
dc.contributor.authorPadrón, José M.-
dc.contributor.authorFernández-Bolaños, José G.-
dc.contributor.authorBurke, Anthony J.-
dc.date.accessioned2024-01-03T12:09:58Z-
dc.date.available2024-01-03T12:09:58Z-
dc.date.issued2023-
dc.identifier.issn22117156pt
dc.identifier.urihttps://hdl.handle.net/10316/111170-
dc.language.isoengpt
dc.publisherElsevierpt
dc.relationWe acknowledge the Fundaç˜ao para a Ciˆencia e a Tecnologia (FCT) for funding through the strategic project to LAQV-REQUIMTE (FCT/ MCTES; UIDB/50006/2020|UIDP/50006/2020). O.L. and J.G.F.-B. thank Grant PID2020-116460RB-I00 funded by MCIN/AEI/10.13039/ 501100011033 and Junta de Andalucía (FQM-134) for financial support. A.T.G.-S. thanks to the Estonian Research Council (PRG1509) for funding. A.G.-B., A.P. and J.M.P. thank the Spanish Government (Project PID2021-123059OB-I00 funded by MCIN/AEI /10.13039/ 501100011033 / FEDER, UE). A.P. thanks the EU Social Fund (FSE) and the Canary Islands ACIISI for a predoctoral grant TESIS2020010055. A. G.-B. thanks the Asociaci´on Espa˜nola Contra el C´ancer (AECC) for a predoctoral grant. We are extremely grateful to COST Action 15135, a Multi-target paradigm for innovative ligand identification in the drug discovery process (MuTaLig). Also, TH thanks both the University of Hradec Kr´alov´e (Faculty of Science) and the Erasmus + program for a travel grant (2019-1-CZ01-KA103-060058)pt
dc.rightsopenAccesspt
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/pt
dc.subjectOxindolept
dc.subjectAlzheimer’s diseasept
dc.subjectCholinesterasept
dc.subjectMono-amine oxidasept
dc.subjectMolecular dockingpt
dc.subjectSTD-NMRpt
dc.subjectContinuous live cell imagingpt
dc.titleN-Substituted 3-Aminooxindoles and N-Propargyl Derivatives: Potential Biological Activities against Alzheimer’s Diseasept
dc.typearticle-
degois.publication.firstPage101032pt
degois.publication.titleResults in Chemistrypt
dc.peerreviewedyespt
dc.identifier.doi10.1016/j.rechem.2023.101032pt
degois.publication.volume6pt
dc.date.embargo2023-01-01*
uc.date.periodoEmbargo0pt
item.grantfulltextopen-
item.cerifentitytypePublications-
item.languageiso639-1en-
item.openairetypearticle-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.fulltextCom Texto completo-
Appears in Collections:I&D CNC - Artigos em Revistas Internacionais
FCTUC Química - Artigos em Revistas Internacionais
FFUC- Artigos em Revistas Internacionais
Files in This Item:
File Description SizeFormat
N-Substituted 3-Aminooxindoles and N-Propargyl Derivatives Potential Biological Activities against Alzheimer's Disease.pdf3.84 MBAdobe PDFView/Open
Show simple item record

Page view(s)

33
checked on May 8, 2024

Download(s)

38
checked on May 8, 2024

Google ScholarTM

Check

Altmetric

Altmetric


This item is licensed under a Creative Commons License Creative Commons